1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Cenntro Inc. closed a private placement on September 15, 2026, after amending its August 25, 2026 purchase agreement on September 14 to raise the offering size. The company received gross proceeds of approximately $57,047,760 and says it will use the money for working capital and general corporate purposes. Shareholders face dilution from the sale of up to 15,120,000 new shares at $3.773 each.
Sale of up to 15,120,000 shares of common stock at $3.773 per share, up from an original offering of up to 12,800,000 shares
Gross proceeds of approximately $57,047,760; private placement closed September 15, 2026
Shares sold to non-U.S. accredited investors under Section 4(a)(2) and Regulation S, without general solicitation
Proceeds intended for working capital and general corporate purposes
Mechanics Bank, a subsidiary of Mechanics Bancorp, completed the sale of approximately $417 million of its remaining performing indirect auto loans to Bank of America's trading desk, at a price near book value with an August 31, 2026 cutoff date. The bank retains about $13 million of runoff auto loans, and the company says the sale will reduce risk, improve liquidity and enhance future profitability. The filing does not quantify any gain, loss or earnings effect.
Sale of approximately $417 million of remaining performing indirect auto loans to Bank of America's trading desk
Loans sold at a price near book value, with an August 31, 2026 cutoff date
Mechanics Bank retains approximately $13 million of runoff auto loans; Westlake Portfolio Management will service loans for both parties
Filing gives no gain, loss or earnings figure from the sale
Impact Biomedical said a Form F-4 registration statement for its proposed merger with Zoar Limited was filed with the SEC on September 10, 2026, and announced it on September 16, 2026. The filing is a step toward closing, which remains subject to SEC effectiveness, Impact stockholder approval, and NYSE American approval of the listing of PubCo shares.
Form F-4 registration statement filed with the SEC on Thursday, September 10, 2026, by Zoar Limited (PubCo)
Closing is subject to SEC effectiveness, Impact stockholder approval, and NYSE American listing approval
Combined company expected to be a pharmaceutical company focused on Active Pharmaceutical Ingredients and intermediates
Ernexa Therapeutics Inc. made a corporate fact sheet and an investor presentation available on September 16, 2026, attached as Exhibits 99.1 and 99.2 to this Form 8-K. The filing does not disclose financial results, guidance, or other new operating figures in its text, and the company said the materials will also be posted on its website on September 17, 2026.
Corporate fact sheet dated September 16, 2026 filed as Exhibit 99.1
Investor presentation dated September 2026 filed as Exhibit 99.2
Materials to be posted at investor.ernexatx.com on September 17, 2026
Information is furnished under Item 7.01, not filed, under the Exchange Act
On September 10, 2026, Aperture AC, a Cayman Islands SPAC, signed a Business Combination Agreement with Atlantic HPC Group Inc. Atlantic stockholders would receive SPAC common stock worth $150 million at $10.00 per share, plus up to 6,000,000 earnout shares tied to share price targets and a data center lease. The deal requires approval from both sets of shareholders, and Aperture public shareholders would be able to request redemption of their shares.
Agreement signed September 10, 2026, with Atlantic HPC Group Inc, a Delaware corporation; Aperture would re-domicile to Delaware and merge with a Merger Sub, with Atlantic as the surviving subsidiary
Merger consideration: SPAC common stock with an aggregate value of $150,000,000, valued at $10.00 per share
Earnout of up to 6,000,000 shares over five years after closing: 1,500,000 shares at a $12.50 VWAP, 1,500,000 more at $15.00, and 3,000,000 if a five-megawatt data center lease with a seven-year term is signed
Closing requires an Aperture extraordinary general meeting and Atlantic stockholder approval; a Form S-4 registration statement is to be filed with the SEC
Apollo Commercial Real Estate Finance (ARI) said it has indefinitely suspended its Direct Stock Purchase and Dividend Reinvestment Plan, starting September 29, 2026. Future dividends will be paid in cash rather than reinvested in ARI stock, which ends a route for participants to buy shares directly.
Plan suspension begins September 29, 2026; the Plan may be terminated later at ARI's discretion
Last direct stock purchases under the Plan will take place September 28, 2026
Last recurring ACH debit is September 25, 2026; funds received on or after September 28, 2026 will be returned to participants by Equiniti Trust Company, LLC
Future ARI dividend payments will be issued in cash
Tenon Medical said holders exercised 572,179 existing warrants at $5.02 per share, bringing gross proceeds of $2,872,338.58, and received new five-year warrants for 858,269 shares at the same price. The deal was announced September 11, 2026 and closed September 14, 2026, with the company stating it will use the proceeds for working capital and general corporate purposes. Shareholders may face dilution if the new warrants are exercised, and the company agreed to register the resale of the underlying shares.
Existing warrants for 572,179 shares were exercised at $5.02 per share, with gross proceeds of $2,872,338.58, according to the filing.
New Series B warrants cover up to 858,269 shares, equal to 150% of the shares issued on exercise, with a $5.02 exercise price and a five-year term.
WallachBeth Capital LLC, the financial advisor, will receive a cash fee of 7% of gross proceeds plus legal expense reimbursement up to $65,000.
Tenon must file a resale registration statement within 30 calendar days of September 11, 2026 and seek effectiveness within 60 days, or 90 days if the SEC conducts a full review.
Battalion Oil Corporation received a letter from NYSE American saying it is back in compliance with the Exchange's continued listing standards. The Exchange had flagged a minimum stockholders' equity deficiency in May 2025, and the company has now met the requirement for two consecutive quarters, ahead of its November 30, 2026 compliance deadline. For shareholders, this removes the listing-standard noncompliance flag on the stock, though the filing does not describe the company's financial results.
NYSE American letter dated September 16, 2026 confirms compliance with Part 10 continued listing standards
Deficiency under Sections 1003(a)(i) and 1003(a)(ii), relating to minimum stockholders' equity, was first noticed on May 30, 2025
Compliance regained two consecutive quarters under Section 1009(f), ahead of the November 30, 2026 deadline
Company will be removed from the Exchange's list of noncompliant issuers and its compliance indicator will no longer be disseminated
On September 14, 2026, Essential Properties Realty Trust and its operating partnership signed an eighth amendment to their Amended and Restated Credit Agreement with Wells Fargo as administrative agent. The amendment raises revolving commitments from $1.0 billion to $1.3 billion, lowers margin pricing, and resets the accordion feature, and the company repaid and terminated its Capital One credit agreement in connection with it. The filing does not give a financial impact beyond these terms.
Revolving Credit Facility commitments increase from $1.0 billion to $1.3 billion, per the amendment dated September 14, 2026.
Margin grid pricing for the Revolving Credit Facility and term loans is reduced.
Accordion feature reset to permit $700.0 million of availability.
Obligations under the Capital One Credit Agreement were repaid in full and that agreement was terminated; Subsidiary Guarantors were released from their guarantee obligations.
Matinas BioPharma's board approved a one-for-fifteen reverse stock split of its common stock, which takes effect at 12:01 a.m. Eastern Time on September 28, 2026, with shares trading on a split-adjusted basis under the symbol MTNB. The filing says each stockholder's ownership percentage and voting power will remain essentially unchanged, and the company states there is no assurance the split will keep its shares listed on the NYSE American.
Reverse split ratio: one-for-fifteen (1:15), approved under authority granted by stockholders on June 23, 2025
Effective date: 12:01 a.m. Eastern Time on September 28, 2026; new CUSIP number 576810 402
Fractional shares will be replaced by a proportional cash payment; holders in brokerage accounts need not act
The company states there can be no assurance the split will enable it to maintain its NYSE American listing
Nuburu said its unaudited financial statements for the three and six months ended June 30, 2026 should no longer be relied upon because of a material error in valuing a convertible note receivable from Tekne S.p.A. The company will restate those results in an amendment to its Q2 2026 Form 10-Q, and the correction increases the value of its assets by $761,001.
Error involved using a Tekne equity value of €15.2 million ($17.4 million) instead of €25.4 million ($29.0 million) to value the note as of June 30, 2026.
Fair value of the Tekne convertible note receivable rises from €20,523,000 ($23,446,999) to €21,189,000 ($24,208,000), an increase of $761,001.
The change in fair value of convertible notes receivable for the three and six months ended June 30, 2026 increases by the same amount.
Audit Committee discussed the restatement with independent auditor WithumSmith+Brown, PC.
Churchill Capital Corp XIII said holders of its IPO units may separately trade the Class A ordinary shares and warrants starting September 18, 2026. Units that are not separated will keep trading as XIIIU, and separated shares and warrants will trade as XIII and XIIIW on the Nasdaq Global Market.
Separate trading begins September 18, 2026 for holders of units sold in the IPO.
Each unit consists of one Class A ordinary share and one-tenth of one redeemable warrant.
Each whole warrant entitles the holder to buy one Class A ordinary share for $11.50.
Holders must have their brokers contact Continental Stock Transfer & Trust Company to separate units.
Norwood Financial Corp's Board of Directors declared a quarterly cash dividend of $0.32 per share, payable November 2, 2026, to holders of record as of October 15, 2026. The dividend matches the per-share amount declared in the second quarter of 2026, so shareholders see no change in the payout.
Dividend of $0.32 per share, payable November 2, 2026
Record date is October 15, 2026
Amount is the same as the per-share dividend declared in the second quarter of 2026
Company reports total assets of $2.9 billion through subsidiary Wayne Bank
Celanese Corporation's Board increased its size from 10 to 11 members and elected Luis Fernandez-Moreno as a director, effective September 16, 2026. The filing describes him as independent under SEC and NYSE standards, with a background in specialty chemicals, and says he has not yet been appointed to any board committee.
Board expanded from 10 to 11 members; Fernandez-Moreno serves until the 2027 Annual Meeting of Shareholders
Board determined he is independent under SEC rules and NYSE listing standards; 10 of 11 directors are independent
Previously served as SVP at Ashland, Inc. (2013-2017) and is a director at Ingevity Corporation since 2016
No committee assignments yet; compensated under the company's non-management director practices
Ernexa Therapeutics appointed Robert J. Spiegel, M.D. as a member of its board of directors, effective immediately, on the recommendation of the Nominating and Corporate Governance Committee. The filing says he will be compensated under the company's board compensation plan and reports no related-party transactions or family relationships with other directors or executives.
Board appointment approved September 14, 2026; effective immediately
Dr. Spiegel's compensation follows the Board of Directors Compensation Plan adopted effective August 15, 2026
Filing reports no reportable transactions with Dr. Spiegel under Item 404(a) of Regulation S-K
AIG said Jon Hancock, Executive Vice President and Chief Executive Officer of General Insurance, will retire and become Senior Advisor effective December 31, 2026. As Senior Advisor he will report to AIG President and CEO Eric Andersen and advise on strategic priorities. The filing describes a planned leadership transition in one business unit rather than a change in financial results.
Jon Hancock, EVP and CEO of General Insurance, will retire and transition to Senior Advisor role
Transition effective December 31, 2026
Hancock will report to Eric Andersen, President & CEO of AIG
Filing cites more than six years in executive roles at AIG and a 40-year insurance career
Regional Management Corp. furnished an investor presentation under Regulation FD for use in meetings with bankers and investors beginning September 17, 2026. The deck mainly restates results for the quarter ended June 30, 2026, including revenue up 6.7% year over year and a net credit loss rate up 30 basis points, so shareholders get no new earnings figures from this filing.
Presentation dated September 17, 2026, furnished as Exhibit 99.1 and posted on the company website
2Q 26 total revenue grew 6.7% year over year, while the net credit loss rate rose 30 bps year over year
Operating expense ratio was 12.4%, improved 80 bps year over year; company entered its 20th state, Florida, in May 2026
As of June 30, 2026, total unused capacity was $442 million and available liquidity was $128 million; fixed-rate debt was 80% of total debt
Sturm Ruger amended its rights agreement with Computershare, moving the final expiration date from October 13, 2026 to September 16, 2026, which terminates the plan at the close of business that day. The company said regulatory conditions under its Strategic Cooperation Agreement with Beretta Holding have been satisfied, and the board decided an active rights plan is no longer necessary.
Final expiration date accelerated from October 13, 2026 to September 16, 2026
Rights Plan terminates at close of business on September 16, 2026; shareholders need take no action
Amendment follows satisfied regulatory conditions under the Beretta Holding Strategic Cooperation Agreement, whose terms remain unchanged
Amendment No. 1 dated September 15, 2026 filed as Exhibit 4.1
Public Storage's subsidiary PS Canada Finance ULC completed a C$400 million offering of 4.540% senior notes maturing September 16, 2033, guaranteed by Public Storage and its subsidiary PSOC. The filing describes a standard debt issuance with covenants limiting mergers and requiring PSOC to keep unencumbered assets at or above 125% of unsecured debt.
Notes: C$400 million, 4.540% fixed interest, payable semi-annually from March 16, 2027
Maturity: September 16, 2033; redeemable at make-whole price, or at 100% of principal plus accrued interest from July 16, 2033
Covenant: PSOC must maintain unencumbered assets of at least 125% of total unsecured indebtedness
Capri Holdings announced that Catherine So, previously General Counsel at Tiffany & Co., will join as Chief Legal and Sustainability Officer effective October 19, 2026, reporting to Chairman and CEO John D. Idol. The filing reports no financial results or guidance, so the appointment is an executive leadership change rather than a change to the company's financial outlook.
Catherine So joins from Tiffany & Co., where she was Senior Vice President and General Counsel
Appointment is effective October 19, 2026
She will report to John D. Idol, Chairman and Chief Executive Officer
The filing contains no financial results or guidance
TEN Holdings appointed Yee Won Hiew to its board of directors, filling a seat vacated in May 2026, and placed her on the Audit and Nominating and Corporate Governance Committees. The board also terminated the share repurchase program approved in March 2025 and authorized a new program of up to $2 million in share repurchases, which the company may suspend or end at any time.
Yee Won Hiew appointed effective September 16, 2026, filling the vacancy left by Randolph Wilson Jones III's May 8, 2026 departure
Hiew receives an annual cash retainer of $10,000 as a non-employee director
New repurchase program authorizes up to $2 million of common stock; the prior program approved in March 2025 was terminated
Kforce Inc. entered into a Rule 10b5-1 stock trading plan on September 15, 2026, to repurchase its common stock under the share repurchase program authorized by its Board of Directors. Repurchases can begin no earlier than September 16, 2026, and run through October 28, 2026, through an independent broker subject to price, market, volume and timing constraints.
Plan entered into on September 15, 2026, under Rule 10b5-1 of the Securities Exchange Act of 1934
Repurchases permitted from September 16, 2026, through October 28, 2026
Repurchases administered by an independent broker within constraints set in the Plan
The filing does not state the number of shares or dollar amount to be repurchased
GEE Group Inc. filed a proxy supplement moving its 2026 virtual Annual Meeting of Shareholders from September 24, 2026 to September 30, 2026. The company said the delay gives it more time to solicit proxies needed to approve the proposals in its August 31, 2026 Proxy Statement, so shareholders who have not yet voted are encouraged to do so.
Annual Meeting moved from 9:00 a.m. EDT on September 24, 2026 to 9:00 a.m. on Wednesday, September 30, 2026, in a virtual format
Reason given: additional time to solicit proxies to approve the proposals in the Proxy Statement
Record date remains the close of business on August 10, 2026; previously submitted proxies remain valid unless revoked
The supplement does not change any other matter in the Proxy Statement
At its September 16, 2026 annual meeting, Powerfleet stockholders re-elected Michael Casey, Ian Jacobs, Andrew Martin and Steve Towe as directors, ratified Deloitte & Touche as auditor for the fiscal year ending March 31, 2027, approved an advisory vote on executive compensation, and approved an amendment to the 2018 Incentive Plan. Ian Jacobs received 13,059,443 votes withheld, the largest withheld total of the four nominees.
Directors re-elected to serve until the 2027 annual meeting: Casey (78,664,423 for, 1,331,931 withheld), Jacobs (66,936,911 for, 13,059,443 withheld), Martin (77,276,560 for, 2,719,794 withheld), Towe (79,282,386 for, 713,968 withheld).
Plan amendment approved with 75,415,953 votes for and 4,463,721 against, with 116,680 abstentions.
Deloitte & Touche ratification received 98,953,471 votes for and 76,257 against.
Shares represented at the meeting: 99,056,956 of 134,023,082 entitled to vote; advisory executive compensation vote received 78,166,408 for and 1,665,813 against.
Greystone Housing Impact Investors LP declared a regular quarterly cash distribution of $0.14 per Beneficial Unit Certificate (BUC), payable October 30, 2026, to holders of record at the close of trading on September 30, 2026. The filing does not state a change from prior distributions, and CEO Ken Rogozinski said the Partnership is exiting market rate multifamily joint venture equity investments, citing the August 2026 sale of Vantage at Loveland, and plans to reinvest in tax-exempt mortgage revenue bonds.
Distribution of $0.14 per BUC, payable October 30, 2026
Record date and ex-distribution date: September 30, 2026
CEO Ken Rogozinski cited the August 2026 sale of Vantage at Loveland as part of the exit from market rate multifamily joint venture equity investments
On September 10, 2026, Empire Petroleum Corporation issued a $3,250,000 promissory note to Petroleum Independent & Exploration, LLC, which has fully advanced the funds for general working capital. The note matures March 10, 2028 and carries 6% annual interest, and PIE may convert principal into common stock at $2.838 per share from November 9, 2026, which would issue 1,145,173 shares if fully converted. The filing adds debt and could dilute existing shareholders if converted, and it contains no revenue, profit or guidance figures.
$3,250,000 note issued September 10, 2026 to PIE; full amount advanced as of that date
6% annual interest, rising to 9% on any principal unpaid after the March 10, 2028 maturity; accrued interest payable in cash at maturity
Convertible at PIE's option from November 9, 2026 to maturity at $2.838 per share, for up to 1,145,173 shares
Prepayable without penalty on at least five business days' written notice; company will seek NYSE American approval for the underlying shares
Owens Corning expanded its board from nine to ten directors and elected Michael J. DeVito as a director, effective September 16, 2026. DeVito will join the Audit Committee and the Finance and Technology Committee, and the board determined he is independent.
Board expanded from nine to ten directors; DeVito elected effective September 16, 2026
DeVito was CEO and Executive Director of Freddie Mac from 2021 to 2024
Previously spent 24 years at Wells Fargo, most recently as Executive Vice President and Head of Home Lending
Will join the Audit Committee and Finance and Technology Committee; currently serves on NVR, Inc. board
TON Strategy Company filed a Form 8-K furnishing an investor presentation dated September 16, 2026, that it will use in meetings with current and prospective investors. The presentation is also posted on the company's website, and the filing states it is furnished rather than filed under the Exchange Act.
Investor presentation dated September 16, 2026 is furnished as Exhibit 99.1
Presentation will be used in meetings with current and prospective investors
Filing is signed by CEO Kevin Wilson and dated September 16, 2026
On September 16, 2026, Teva's subsidiaries issued €1.5 billion and $3.2 billion of senior unsecured notes due 2032 to 2037, guaranteed by Teva Pharmaceutical Industries. Teva plans to use the proceeds to fund conditional redemptions of several existing notes, pay related fees, and for general corporate purposes. The filing shows a refinancing of existing debt rather than a stated change in operations or results.
Euro notes: €1.0 billion of 4.250% notes due March 16, 2033, and €500 million of 4.625% notes due September 16, 2036
USD notes: $1.2 billion of 5.250% notes due January 16, 2032; $1.0 billion of 5.500% notes due January 16, 2034; and $1.0 billion of 5.750% notes due January 16, 2037
Conditional redemptions include up to $450 million of 4.750% notes due 2027 and up to €1.15 billion of 4.375% notes due 2030, reduced from up to €1.25 billion
Teva may redeem notes, or issue further redemption notices, at its sole discretion and is under no obligation to do so
Sandisk's Compensation and Talent Committee approved compensation adjustments for Chief Technology Officer Alper Ilkbahar and Chief Legal Officer Bernard Shek on September 10, 2026, following an annual review of executive pay. The changes take effect October 1, 2026, and the filing does not state the prior salary levels, so the size of the increases cannot be determined from it.
Ilkbahar (CTO): annual base salary of $755,000 and annual short-term incentive target of 100% of base salary.
Shek (CLO): annual base salary of $618,000 and annual short-term incentive target of 100% of base salary.
CEO David Goeckeler's base salary ($1,300,000) and CFO Luis Visoso's base salary ($875,000) were not changed; the filing states no changes to Goeckeler's base salary.
Generac agreed to issue Amazon a warrant to buy up to 1,693,745 common shares at $200.9266 per share, alongside a long-term backup generator supply agreement. The warrant vests in tranches tied to gross payments from Amazon and its affiliates, up to $8 billion in total, and can be exercised through September 16, 2033.
Warrant covers up to 1,693,745 shares at $200.9266 per share; 307,954 shares vested immediately.
Vesting tied to aggregate gross payments, net of certain offsets, from Amazon for backup generators for Amazon data centers, up to $8 billion.
Initial backup generator deliveries are expected to total $2.4 billion in 2027 and 2028.
Warrant is exercisable on or before September 16, 2033; shares issued without SEC registration under Section 4(a)(2).
NIKE's board increased its size to twelve directors and appointed Alexandre Arnault, Deputy CEO of Moët Hennessy at LVMH, as a director effective immediately on September 15, 2026. The filing says his committee assignments have not yet been determined, and he received a $200,000 sign-on award of restricted Class B shares that is forfeitable if he leaves the board before the first anniversary of the grant.
Board expanded to twelve directors; Arnault's initial term runs to the 2027 annual meeting of shareholders
Arnault, 34, has been Deputy CEO of Moët Hennessy since February 2025 and has served on the LVMH board since April 2024
Sign-on award of restricted Class B Common Stock valued at $200,000, granted September 15, 2026
Committee assignments for Arnault have not yet been determined
Selective Insurance Group expanded its board from 12 to 13 members and appointed Wole C. Coaxum as a non-employee director, effective September 16, 2026. He previously served on the board from 2020 to 2025 and joined the Audit Committee and Compensation and Human Capital Committee. The filing describes a board appointment with no financial results, guidance or deal terms included, so it has no direct effect on reported performance.
Board increased from 12 to 13 members; 12 of 13 directors are independent
Coaxum named to the Audit Committee and Compensation and Human Capital Committee
Term runs until the 2027 Annual Meeting of Stockholders; no fiscal 2026 equity award, cash retainer prorated through December 31, 2026
Coaxum is founder and CEO of On Our Block and previously led digital banking platform MoCaFi until its 2026 wind-down
AES disclosed that Bernerd Da Santos, who had moved from President of US & Renewables to Chairman of the AES Clean Energy Board in April 2026, left the company effective September 14, 2026, to become Executive Vice President and Chief Operating Officer at Fluence Energy, Inc. His separation agreement provides severance under the company's executive severance plan, which matters to shareholders because it is a cost tied to a senior leadership departure.
Departure effective September 14, 2026; he accepted a role as EVP and COO at Fluence Energy, Inc.
Severance equal to one times annualized base salary plus annual target bonus for fiscal 2026, plus a pro-rata fiscal 2026 bonus at target performance
He will also receive applicable retirement benefits under company plans; the filing gives no dollar amounts
Full separation agreement to be filed as an exhibit to the Form 10-Q for the quarter ending September 30, 2026
TrustCo Bank Corp NY's board voted unanimously on September 15, 2026 to increase its size from nine to eleven directors and elected Patricia Kieper-Fusco and Bryan L. Guentner to fill the new seats, effective immediately. The filing describes the change as a governance update and does not report any financial results or compensatory equity awards tied to the appointments.
Board expanded from nine to eleven directors; Patricia Kieper-Fusco and Bryan L. Guentner elected effective immediately on September 15, 2026
Both directors also join the board of subsidiary Trustco Bank and were appointed to the Audit, Board Compliance, Compensation, Fiduciary, Nominating and Corporate Governance, and Risk Committees
Board found both directors independent under Nasdaq standards; no equity awards made in connection with their elections
On September 15, 2026, Nelnet's board increased its size from eight to ten members and appointed Angela Klein and Edward Pallesen as independent directors. The company will pay their pro rata director retainers in Class A common stock, about $141,000 and $133,000, through its 2027 annual meeting.
Board increased from eight to ten members on September 15, 2026.
Angela Klein appointed Class III director with a term expiring at the 2029 annual meeting; Edward Pallesen appointed Class II director with a term expiring at the 2028 annual meeting.
Pro rata retainers of approximately $141,000 (Klein) and $133,000 (Pallesen) paid in Class A stock under the Directors Stock Compensation Plan.
Vivani Medical disclosed in a Regulation FD filing that it expects pricing and closing of the previously announced merger of its subsidiary Cortigent into a ClearOne subsidiary to occur in October 2026. The filing reiterates the transaction structure but gives no financial terms, and it carries a risk that the deal may not be completed.
Cortigent, a wholly owned Vivani subsidiary, will merge with and into CLRO Merger Sub, Inc., becoming a wholly owned subsidiary of ClearOne, Inc.
Vivani anticipates pricing and closing of the Transaction in October 2026.
Forward-looking statements cite the Company's inability to consummate the Transaction as a key risk.
BrightSpire Capital's subsidiaries completed the sale of the Net Lease 1 Investment, two industrial properties in Tolleson, Arizona and Tracy, California, on September 14, 2026, under a purchase agreement dated June 12, 2026. The total consideration was $300.0 million, including $97.9 million in cash net of closing costs, with the rest covered by the buyers assuming existing loans. The filing's pro forma figures show an approximate $60.4 million gain on sale, but these are illustrative and not actual reported results.
Total consideration of $300.0 million: $97.9 million in cash net of closing and other transaction expenses, plus assumed loans.
Buyers assumed a mortgage loan with an original principal amount of $94.0 million and a mezzanine loan with an original principal amount of $106.0 million.
Pro forma statements show an approximate $60.4 million gain on sale and a pro forma net income of $27.7 million for 2025, compared with a historical net loss of $31.1 million attributable to common stockholders.
Pro forma figures assume the sale occurred January 1, 2025, and the filing states they should not indicate future results.
EagleRock Land's board approved 2026 long-term incentive awards on September 10, 2026, including performance share units for CEO Greg Pipkin Jr. and CFO Neal H. Shah. The filing describes vesting tied to total shareholder return over a performance period ending May 14, 2029, and the awards are subject to the company's clawback policies.
CEO Greg Pipkin Jr. received 270,147 PSUs at target, all in performance share units.
CFO Neal H. Shah received 71,429 PSUs at target and 47,619 RSUs, a 60%/40% split.
PSUs are earned based on relative and absolute TSR over a performance period from May 14, 2026 to May 14, 2029, capped at 250% of target.
RSUs vest in three equal annual installments; the board approved the awards on September 10, 2026.
Avalyn Pharma's board appointed Robert Meyer, M.D. as a Class II director effective September 15, 2026, with a term expiring at the 2028 annual meeting. The board determined he is independent under Nasdaq listing standards, and he brings prior FDA and drug-regulatory experience.
Robert Meyer, M.D. appointed Class II director effective September 15, 2026; term expires at the 2028 annual meeting
Annual director retainer of $40,000 under the Non-Employee Director Compensation Policy
Initial option grant for 31,182 shares of common stock, vesting in equal annual installments over three years
Martin Marietta and its subsidiary Martin Marietta Funding LLC signed an amendment on September 15, 2026, extending the maturity of their $500 million trade receivables securitization facility to September 15, 2027. The facility can be increased to up to $700 million if lenders provide the required commitments, and borrowings now bear interest at Adjusted Term SOFR plus 0.700%.
Maturity extended to September 15, 2027 under the Eighteenth Amendment with Truist Bank as administrative agent
Facility size is $500 million, with a possible increase to up to $700 million subject to conditions
Borrowings bear interest at Adjusted Term SOFR plus 0.700%, subject to change if SOFR benchmarks cannot be determined or no longer reflect lenders' cost of lending
AECOM said Chief Legal Officer David Gan will retire, with his role passing to Manav Kumar, the company's General Counsel, Corporate and Global Head of Public Affairs, effective October 2, 2026. Gan will then serve as Senior Advisor until his retirement in the second half of 2027. The filing describes a planned leadership transition with no financial results or guidance included.
David Gan provided notice of retirement on September 14, 2026, and remains in his role through October 2, 2026.
Manav Kumar, age 42, becomes Chief Legal Officer effective October 2, 2026, and has been General Counsel, Corporate and Global Head of Public Affairs since December 2024.
Gan keeps his existing base salary as Senior Advisor until his retirement in the second half of 2027.
Gan remains eligible for a fiscal year 2026 annual incentive bonus but will not participate in annual or long-term incentive programs in fiscal year 2027.
Horizon Bancorp's board approved a dividend of $0.16 per share on September 15, 2026. The dividend is payable October 16, 2026 to stockholders of record on October 2, 2026, so holders on that record date will receive the payment.
Dividend amount: $0.16 per share
Record date: October 2, 2026
Payment date: October 16, 2026
Approved by the Board of Directors on September 15, 2026
Pasithea Therapeutics said its warrants under symbol KTTAW will expire on September 17, 2026, under their terms and the warrant agency agreement with VStock Transfer, LLC. Unexercised warrants will stop being exercisable and will have no further value, and the warrants will cease trading on Nasdaq and be delisted and deregistered. The company's common stock, KTTA, will continue to trade on Nasdaq.
Warrants (KTTAW) expire on September 17, 2026
Unexercised warrants cease to be exercisable and have no further value
Warrants to be removed from Nasdaq listing via Form 25 filing
Gossamer Bio appointed Gregory A. Ciongoli as a Class III director effective September 16, 2026, with a term expiring at the 2027 annual meeting, and also named him to the Audit Committee. The Board determined he is independent under Nasdaq listing rules, and he is a purchaser in the 2026 private placement, so his board seat ties him to securities he has agreed to buy in the company.
Appointed Class III director effective September 16, 2026; initial term expires at the 2027 annual meeting of stockholders
Receives a $40,000 annual cash retainer for Board service and a $7,500 annual cash retainer for Audit Committee service
Purchased initial closing pre-funded warrants in the 2026 PIPE (initial closing August 24, 2026) and agreed to buy second closing and FDA approval warrants
Board determined he is independent under Nasdaq Global Select Market listing requirements
Oaktree Specialty Lending Corporation issued $300.0 million of 7.000% unsecured notes maturing September 16, 2031, and the transaction closed the same day. The company expects to use the net proceeds to reduce borrowings under its senior secured revolving credit facility and for general corporate purposes, which may include repaying 2.700% notes due 2027 at maturity.
Notes: $300.0 million aggregate principal, 7.000% annual interest, paid semiannually on March 16 and September 16 starting March 16, 2027
Maturity September 16, 2031; callable at a make-whole price (Treasury Rate plus 40 basis points) before August 16, 2031, and at par thereafter
Holders may require repurchase at 100% of principal plus accrued interest upon a Change of Control Repurchase Event
Offering made under shelf registration No. 333-292920; transaction closed September 16, 2026
Viper Energy's board increased its size by one seat and appointed geologist John Grotzinger as a director on September 15, 2026. The filing describes his scientific background and compensation terms, and states he has no committee assignment yet. For shareholders, this is a routine board addition that does not change financial results or guidance.
Appointed September 15, 2026; board expanded to nine directors
Grotzinger is Harold Brown Professor of Geology at Caltech and a former NASA Mars Science Laboratory Curiosity chief scientist
Receives non-employee director pay plus a pro-rated annual restricted stock unit award
CB Financial Services extended the termination date of its previously announced program to repurchase up to $5.0 million of its common stock to August 31, 2027, from September 30, 2026. The extension keeps the buyback authorization in place for an additional year without changing the program's size.
Repurchase program covers up to $5.0 million of outstanding common stock.
Program was set to terminate on September 30, 2026; now extended to August 31, 2027.
Extension announced September 16, 2026, in a filing signed by CFO Amanda L. Engles.
Great Southern Bancorp, the holding company for Great Southern Bank, declared a $0.43 per common share dividend for the third quarter of 2026. The filing describes it as the 147th consecutive quarterly dividend paid to common stockholders, and it does not report any change in the amount from prior periods or any financial results.
Dividend: $0.43 per common share for the third quarter of 2026
Record date: September 28, 2026; payable October 14, 2026
Filing describes this as the 147th consecutive quarterly common dividend
Insulet's Talent and Compensation Committee approved a nonqualified deferred compensation plan on September 14, 2026, effective January 1, 2027, letting selected management and highly compensated employees defer up to 60% of cash pay. The plan also allows discretionary company contributions, with vesting tied to service and full vesting on a change in control.
Plan approved September 14, 2026 and effective January 1, 2027
Participants may defer up to 60% of base salary, annual bonus and other approved cash compensation
Company matching or discretionary contributions generally vest on a two-year cliff schedule and fully vest on a change in control
Committee can terminate or amend the plan, but cannot reduce accrued participant benefits
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.